Cassandra A Stanton1, Diana R Keith2, Diann E Gaalema2, Janice Y Bunn2, Nathan J Doogan3, Ryan Redner4, Allison N Kurti2, Megan E Roberts3, Stephen T Higgins2. 1. Westat, Center for Evaluation and Coordination of Training and Research (CECTR) in Tobacco Regulatory Science, United States; Department of Oncology, Georgetown University Medical Center, Cancer Prevention and Control Program, Lombardi Comprehensive Cancer Center, United States. Electronic address: CassandraStanton@westat.com. 2. Vermont Center on Tobacco Regulatory Science, University of Vermont, United States. 3. College of Public Health, The Ohio State University, United States. 4. Vermont Center on Tobacco Regulatory Science, University of Vermont, United States; Rehabilitation Institute, Southern Illinois University, Carbondale, United States.
Abstract
INTRODUCTION: Chronic conditions are among the most common and costly of all health problems. Addressing tobacco use among adults with chronic conditions is a public health priority due to high prevalence as well as greater potential harm from continued use. METHODS: Data were drawn from 9years (2005-2013) of the U.S. National Survey on Drug Use and Health. Adult (≥18years) tobacco use included any past 30-day use of cigarettes, cigars, pipes, or smokeless tobacco. Chronic conditions examined included anxiety, asthma, coronary heart disease, depression, diabetes, hepatitis, HIV, hypertension, lung cancer, stroke, and substance abuse. Controlling for sociodemographics, trends in product use for most conditions and a composite of any condition among those with chronic conditions were compared to respondents with no condition in weighted logistic regression analyses. RESULTS: Cigarette smoking declined significantly over time among adults with no chronic condition. Adults with one or more chronic condition showed no comparable decrease, with cigarette smoking remaining especially high among those reporting anxiety, depression, and substance abuse. Cigar and pipe use remained stable and more prevalent among those with any chronic condition, with the exception of pipe use declining among those with heart disease. Smokeless tobacco use increased over time, with higher prevalence among those with asthma, mental health, and substance abuse conditions. CONCLUSIONS: These findings have tobacco control and regulatory implications for addressing higher tobacco use among adults with chronic conditions. Provider advice and cessation resources targeting tobacco use among those with chronic conditions are recommended.
INTRODUCTION: Chronic conditions are among the most common and costly of all health problems. Addressing tobacco use among adults with chronic conditions is a public health priority due to high prevalence as well as greater potential harm from continued use. METHODS: Data were drawn from 9years (2005-2013) of the U.S. National Survey on Drug Use and Health. Adult (≥18years) tobacco use included any past 30-day use of cigarettes, cigars, pipes, or smokeless tobacco. Chronic conditions examined included anxiety, asthma, coronary heart disease, depression, diabetes, hepatitis, HIV, hypertension, lung cancer, stroke, and substance abuse. Controlling for sociodemographics, trends in product use for most conditions and a composite of any condition among those with chronic conditions were compared to respondents with no condition in weighted logistic regression analyses. RESULTS: Cigarette smoking declined significantly over time among adults with no chronic condition. Adults with one or more chronic condition showed no comparable decrease, with cigarette smoking remaining especially high among those reporting anxiety, depression, and substance abuse. Cigar and pipe use remained stable and more prevalent among those with any chronic condition, with the exception of pipe use declining among those with heart disease. Smokeless tobacco use increased over time, with higher prevalence among those with asthma, mental health, and substance abuse conditions. CONCLUSIONS: These findings have tobacco control and regulatory implications for addressing higher tobacco use among adults with chronic conditions. Provider advice and cessation resources targeting tobacco use among those with chronic conditions are recommended.
Authors: Joseph Guydish; Emma Passalacqua; Barbara Tajima; Mable Chan; Jongserl Chun; Alan Bostrom Journal: Nicotine Tob Res Date: 2011-04-04 Impact factor: 4.244
Authors: Kenneth A LaBresh; Gregg C Fonarow; Sidney C Smith; Robert O Bonow; Lynn C Smaha; Patricia A Tyler; Yuling Hong; Dawn Albright; A Gray Ellrodt Journal: Crit Pathw Cardiol Date: 2007-09
Authors: Richard A Goodman; Samuel F Posner; Elbert S Huang; Anand K Parekh; Howard K Koh Journal: Prev Chronic Dis Date: 2013-04-25 Impact factor: 2.830
Authors: Israel T Agaku; Brian A King; Corinne G Husten; Rebecca Bunnell; Bridget K Ambrose; S Sean Hu; Enver Holder-Hayes; Hannah R Day Journal: MMWR Morb Mortal Wkly Rep Date: 2014-06-27 Impact factor: 17.586
Authors: Diana R Keith; Cassandra A Stanton; Diann E Gaalema; Janice Y Bunn; Nathan J Doogan; Ryan Redner; Allison N Kurti; Antonio Cepeda-Benito; Alexa A Lopez; Adam L Morehead; Megan E Roberts; Stephen T Higgins Journal: J Gen Intern Med Date: 2017-05-03 Impact factor: 5.128
Authors: A Feinberg; P M Lopez; K Wyka; N Islam; L Seidl; E Drackett; A Mata; J Pinzon; M R Baker; J Lopez; C Trinh-Shevrin; D Shelley; Z Bailey; K A Maybank; L E Thorpe Journal: J Urban Health Date: 2017-08 Impact factor: 3.671
Authors: N J Doogan; M E Roberts; M E Wewers; C A Stanton; D R Keith; D E Gaalema; A N Kurti; R Redner; A Cepeda-Benito; J Y Bunn; A A Lopez; S T Higgins Journal: Prev Med Date: 2017-03-16 Impact factor: 4.018
Authors: Stephen T Higgins; Allison N Kurti; Marissa Palmer; Jennifer W Tidey; Antonio Cepeda-Benito; Maria R Cooper; Nicolle M Krebs; Lourdes Baezconde-Garbanati; Joy L Hart; Cassandra A Stanton Journal: Prev Med Date: 2019-05-02 Impact factor: 4.018